更正：MUC1促进三阴性乳腺癌中的代谢组重编程。
Correction: MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.
作者信息
Goode Gennifer, Gunda Venugopal, Chaika Nina V, Purohit Vinee, Yu Fang, Singh Pankaj K
出版信息
PLoS One. 2017 Jun 1;12(6):e0179098. doi: 10.1371/journal.pone.0179098. eCollection 2017.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0176820.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0176820。]
相似文献
1
Correction: MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.更正：MUC1促进三阴性乳腺癌中的代谢组重编程。
PLoS One. 2017 Jun 1;12(6):e0179098. doi: 10.1371/journal.pone.0179098. eCollection 2017.
2
Correction: Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.更正：用光镊表征乳腺癌相关MUC1粘蛋白与C型凝集素之间的相互作用。
PLoS One. 2018 Jan 2;13(1):e0190814. doi: 10.1371/journal.pone.0190814. eCollection 2018.
3
Correction: A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer.更正：一种基于网络的数据整合方法，用于支持三阴性乳腺癌中的药物再利用和多靶点治疗。
PLoS One. 2017 Jan 11;12(1):e0170363. doi: 10.1371/journal.pone.0170363. eCollection 2017.
4
Correction: The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.更正：天然化合物麻风树素干扰Wnt/β-连环蛋白信号传导并抑制人三阴性乳腺癌的增殖和上皮-间质转化。
PLoS One. 2018 May 17;13(5):e0197796. doi: 10.1371/journal.pone.0197796. eCollection 2018.
5
Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.更正：除腋窝淋巴结转移外，体重指数和绝经状态是新辅助化疗治疗三阴性乳腺癌的预后决定因素。
PLoS One. 2016 Jul 7;11(7):e0159123. doi: 10.1371/journal.pone.0159123. eCollection 2016.
6
Correction: Elevated levels of eEF1A2 protein expression in triple negative breast cancer relate with poor prognosis.更正：三阴性乳腺癌中eEF1A2蛋白表达水平升高与预后不良相关。
PLoS One. 2019 Dec 19;14(12):e0227068. doi: 10.1371/journal.pone.0227068. eCollection 2019.
7
Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.更正：GeparSixto试验中三阴性乳腺癌的MGMT启动子甲基化
PLoS One. 2021 Sep 1;16(9):e0257142. doi: 10.1371/journal.pone.0257142. eCollection 2021.
8
Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth.勘误：靶向肿瘤MUC1糖蛋白的嵌合抗原受体T细胞可降低三阴性乳腺癌的生长。
Front Immunol. 2020 Dec 7;11:628776. doi: 10.3389/fimmu.2020.628776. eCollection 2020.
9
Correction: Dexamethasone Treatment Induces the Reprogramming of Pancreatic Acinar Cells to Hepatocytes and Ductal Cells.更正：地塞米松治疗可诱导胰腺腺泡细胞重编程为肝细胞和导管细胞。
PLoS One. 2019 Jul 2;14(7):e0219419. doi: 10.1371/journal.pone.0219419. eCollection 2019.
10
Correction: Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.更正：老年女性雌激素受体阴性的早期可手术原发性乳腺癌——生物学特征与长期临床结局
PLoS One. 2018 Jan 25;13(1):e0191979. doi: 10.1371/journal.pone.0191979. eCollection 2018.
本文引用的文献
1
MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.黏蛋白1（MUC1）促进三阴性乳腺癌中的代谢重编程。
PLoS One. 2017 May 2;12(5):e0176820. doi: 10.1371/journal.pone.0176820. eCollection 2017.
Zotero 插件